| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 148 |
| 1 | METHOTREXATE SODIUM | 130 |
| 2 | METHOTREXATE | 119 |
| 3 | CYCLOPHOSPHAMIDE | 106 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 106 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 106 |
| 6 | INTERFERON BETA-1A | 80 |
| 7 | DEXAMETHASONE | 75 |
| 8 | BACLOFEN | 74 |
| 9 | DEXAMETHASONE 1.5 MG | 74 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN SODIUM, SULBACTAM SODIUM | 1 | 0.0263 |
| 1 | DEXTROSE AND SODIUM CHLORIDE | 2 | 0.0120 |
| 2 | TOLCAPONE | 4 | 0.0114 |
| 3 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 4 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 3 | 0.0076 |
| 5 | NELARABINE | 7 | 0.0072 |
| 6 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 7 | FINGOLIMOD HYDROCHLORIDE | 33 | 0.0065 |
| 8 | SONIDEGIB | 7 | 0.0042 |
| 9 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 250 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 171 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 130 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 126 |
| 4 | Alkylating Drug [EPC] | 122 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 111 |
| 6 | Benzodiazepine [EPC] | 88 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 86 |
| 8 | Interferon beta [EPC] | 81 |
| 9 | Integrin Receptor Antagonist [EPC] | 75 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 45 | 0.0032 |
| 1 | Osmotic Diuretic [EPC] | 14 | 0.0027 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | Thyroid Stimulating Hormone [EPC] | 2 | 0.0019 |
| 4 | Provitamin D2 Compound [EPC] | 52 | 0.0017 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 27 | 0.0014 |
| 7 | Antiparasitic [EPC] | 6 | 0.0013 |
| 8 | Pediculicide [EPC] | 6 | 0.0013 |
| 9 | Methylating Agent [EPC] | 1 | 0.0010 |